Lupin in partnership with Pharmascience Inc today announced that it has received tentative approval from the United States Food and Drug Administration FDA for its Abbreviated New Drug Application ANDA Dasatinib Tablets 20 mg 50 mg 70 mg 80 mg 100 mg and 140 mg to market a generic equivalent of Sprycel Tablets 20 mg 50 mg 70 mg 80 mg 100 mg and 140 mg of Bristol-Myers Squibb Company Dasatinib Tablets RLD Sprycel had estimated annual sales of USD 1569 million in the US IQVIA MAT June 2022
Related Tags
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.